We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Updated: 2/23/2017
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Updated: 2/23/2017
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Status: Enrolling
Updated: 2/23/2017
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Updated: 2/23/2017
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
Updated: 2/23/2017
Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol
Status: Enrolling
Updated: 2/23/2017
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
Updated: 2/23/2017
Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Improving Anticoagulation Control in VISN 1
Updated: 2/28/2017
Improving Anticoagulation Control in VISN 1
Status: Enrolling
Updated: 2/28/2017
Improving Anticoagulation Control in VISN 1
Updated: 2/28/2017
Improving Anticoagulation Control in VISN 1
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Updated: 2/28/2017
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Updated: 2/28/2017
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Updated: 2/28/2017
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Updated: 2/28/2017
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
PLATINUM Diversity
Updated: 3/2/2017
PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials